Clinical Trials : Diffuse Cutaneous Systemic Sclerosis

Completed

Study Name: Serial Night Time Position Splint on Systemic Sclerosis
Condition: Diffuse Systemic Sclerosis
Date: 2012-04-25
Interventions:

Device: Serial night time position splint

Completed

Study Name: Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma
Condition: Systemic Sclerosis
Date: 2008-06-23
Interventions:

Drug: Relaxin 10 ug/kg/day or

Completed

Study Name: Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma
Condition: Scleroderma
Date: 2015-01-26
Interventions:

Drug: atorvastatin Atorvastati

Completed

Study Name: Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis
Condition: Systemic Sclerosis
Date: 2016-09-30
Interventions:

Drug: SAR156597 (ACT14604) Pha

Active, not recruiting

Study Name: IVIG Treatment in Systemic Sclerosis
Condition:

Systemic Sclerosis
Diffuse Scleroderma

Date: 2013-01-28
Interventions: Biological: Privigen Subjects will receive 2 g/kg/mo of Privigen® for 6 months if randomized to the

Terminated

Study Name: Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
Condition: Scleroderma
Date: 2012-03-01
Interventions:

Drug: Imatinib mesylate 200 mg

Completed

Study Name: Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis
Condition:

Scleroderma
Cardiac Involvement
Autologous Stem Cell Trans
Date: 2013-07-01
Interventions: Drug: Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells If

Completed

Study Name: Autologous SCT for Progressive Systemic Sclerosis: a Prospective NIS Study
Condition: Autoimmune Diseases
Date: 2014-09-26
Interventions: Procedure: Autologous HSCT 1st AHSCT

Completed

Study Name: Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis
Condition:

Systemic Sclerosis
Scleroderma

Date: 2010-03-24
Interventions: Drug: Ambrisentan Drug is dispensed in tablet form. Ambris

Completed

Study Name: High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis
Condition: Scleroderma, Diffuse
Date: 2007-01-29
Interventions: Drug: N-acetylcysteine (NAC)

Search for Clinical Trial Results

Diffuse Cutaneous Systemic Sclerosis - 23 Studies Found

Status	Study
Completed	Study Name: Serial Night Time Position Splint on Systemic Sclerosis Condition: Diffuse Systemic Sclerosis Date: 2012-04-25 Interventions: Device: Serial night time position splint
Completed	Study Name: Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma Condition: Systemic Sclerosis Date: 2008-06-23 Interventions: Drug: Relaxin 10 ug/kg/day or
Completed	Study Name: Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma Condition: Scleroderma Date: 2015-01-26 Interventions: Drug: atorvastatin Atorvastati
Completed	Study Name: Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis Condition: Systemic Sclerosis Date: 2016-09-30 Interventions: Drug: SAR156597 (ACT14604) Pha
Active, not recruiting	Study Name: IVIG Treatment in Systemic Sclerosis Condition: Systemic Sclerosis Diffuse Scleroderma Date: 2013-01-28 Interventions: Biological: Privigen Subjects will receive 2 g/kg/mo of Privigen® for 6 months if randomized to the
Terminated	Study Name: Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma Condition: Scleroderma Date: 2012-03-01 Interventions: Drug: Imatinib mesylate 200 mg
Completed	Study Name: Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis Condition: Scleroderma Cardiac Involvement Autologous Stem Cell Trans Date: 2013-07-01 Interventions: Drug: Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells If
Completed	Study Name: Autologous SCT for Progressive Systemic Sclerosis: a Prospective NIS Study Condition: Autoimmune Diseases Date: 2014-09-26 Interventions: Procedure: Autologous HSCT 1st AHSCT
Completed	Study Name: Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis Condition: Systemic Sclerosis Scleroderma Date: 2010-03-24 Interventions: Drug: Ambrisentan Drug is dispensed in tablet form. Ambris
Completed	Study Name: High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis Condition: Scleroderma, Diffuse Date: 2007-01-29 Interventions: Drug: N-acetylcysteine (NAC)